ArticleNeuroradiology2017

Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma.

Lei Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.